326 related articles for article (PubMed ID: 24761867)
1. Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy.
Bhatti AB; Khan AI; Siddiqui N; Muzaffar N; Syed AA; Shah MA; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(6):2577-81. PubMed ID: 24761867
[TBL] [Abstract][Full Text] [Related]
2. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
Li H; Chen Y; Wang X; Tang L; Guan X
Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study.
Li CY; Zhang S; Zhang XB; Wang P; Hou GF; Zhang J
Asian Pac J Cancer Prev; 2013; 14(6):3779-84. PubMed ID: 23886182
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy.
Kim S; Park HS; Kim JY; Ryu J; Park S; Kim SI
Yonsei Med J; 2016 Sep; 57(5):1192-8. PubMed ID: 27401651
[TBL] [Abstract][Full Text] [Related]
5. Breast-conserving therapy for triple-negative breast cancer.
Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery.
Chung A; Gangi A; Mirocha J; Giuliano A
Ann Surg Oncol; 2015 Apr; 22(4):1128-32. PubMed ID: 25300606
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
Wang K; Zhu GQ; Shi Y; Li ZY; Zhang X; Li HY
Clin Breast Cancer; 2019 Feb; 19(1):e101-e115. PubMed ID: 30502219
[TBL] [Abstract][Full Text] [Related]
8. Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
Fastner G; Hauser-Kronberger C; Moder A; Reitsamer R; Zehentmayr F; Kopp P; Fussl C; Fischer T; Deutschmann H; Sedlmayer F
Strahlenther Onkol; 2016 Jan; 192(1):1-7. PubMed ID: 26403912
[TBL] [Abstract][Full Text] [Related]
9. Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients.
Laurberg T; Alsner J; Tramm T; Jensen V; Lyngholm CD; Christiansen PM; Overgaard J
Acta Oncol; 2017 Jan; 56(1):59-67. PubMed ID: 27846764
[TBL] [Abstract][Full Text] [Related]
10. Eight Year Survival Analysis of Patients with Triple Negative Breast Cancer in India.
Chandra D; Suresh P; Sinha R; Azam S; Batra U; Talwar V; Kumar K; Mehta A
Asian Pac J Cancer Prev; 2016; 17(6):2995-9. PubMed ID: 27356724
[TBL] [Abstract][Full Text] [Related]
11. The effect of surgery type on survival and recurrence in very young women with breast cancer.
Quan ML; Paszat LF; Fernandes KA; Sutradhar R; McCready DR; Rakovitch E; Warner E; Wright FC; Hodgson N; Brackstone M; Baxter NN
J Surg Oncol; 2017 Feb; 115(2):122-130. PubMed ID: 28054348
[TBL] [Abstract][Full Text] [Related]
12. Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?
Jones T; Neboori H; Wu H; Yang Q; Haffty BG; Evans S; Higgins S; Moran MS
Ann Surg Oncol; 2013 Sep; 20(9):2866-72. PubMed ID: 23661183
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results: double lumpectomies for multicentric breast carcinoma.
Kapoor NS; Chung A; Huynh K; Giuliano AE
Am Surg; 2012 Dec; 78(12):1345-8. PubMed ID: 23265123
[TBL] [Abstract][Full Text] [Related]
14. Management of positive margins after initial lumpectomy in elderly women with breast cancer.
Angarita FA; Acuna SA; McCready DR; Escallon J
Eur J Surg Oncol; 2018 Jul; 44(7):1048-1053. PubMed ID: 29525464
[TBL] [Abstract][Full Text] [Related]
15. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
16. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors and patterns of recurrence in patients with triple negative breast cancer.
Steward L; Conant L; Gao F; Margenthaler JA
Ann Surg Oncol; 2014 Jul; 21(7):2165-71. PubMed ID: 24558065
[TBL] [Abstract][Full Text] [Related]
18. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns.
Tzikas AK; Nemes S; Linderholm BK
Breast Cancer Res Treat; 2020 Aug; 182(3):643-654. PubMed ID: 32524352
[TBL] [Abstract][Full Text] [Related]
19. Safe negative margin width in breast conservative therapy: results from a population with a high percentage of negative prognostic factors.
Bhatti AB; Khan A; Muzaffar N; Siddiqui N; Syed A; Shah M; Aamir A; Jamshed A
World J Surg; 2014 Nov; 38(11):2863-70. PubMed ID: 24870389
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
